Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.

Clinical trials sponsored by Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd., explained in plain language.

Not yet recruiting 1

New cell therapy tested for Tough-to-Treat blood cancer

Disease control Not yet recruiting

This is an early-stage study testing a new cell therapy called B019 injection in patients whose B-cell non-Hodgkin's lymphoma has returned or not responded to previous treatments. The main goals are to find a safe dose and see how well patients tolerate the treatment, while also …

Phase: PHASE1 • Sponsor: Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. • Aim: Disease control

Last updated Apr 04, 2026 09:35 UTC